People · Operator
Named in public records as an officer, director or promoter · active 2015–2018 · Software / Tech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nikola Labs Inc. | — | Software / Tech | Series C | $149.5M | $541.1M | 2018 |
| QSAM Biosciences, Inc. | — | Biotechnology | Series A | $13.8M | $11.3M | 2015 |
Michelle Murcia at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michelle Murcia on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Flavio Lobato | 1 | 17 |
| Rodolfo Bellesi | 1 | 13 |
| Robert Lee | 1 | 12 |
| David Moritz | 1 | 9 |
| John D'Orazio | 1 | 8 |
| John Young | 1 | 7 |
| Christopher Nelson | 1 | 5 |
| Christopher J. Spencer | 1 | 3 |
| Mark Davidson | 1 | 3 |
| Douglas Baum | 1 | 3 |
| David Mount | 1 | 3 |
| Brian Graham | 1 | 3 |
| C. Richard Piazza | 1 | 2 |
| William Ruff | 1 | 2 |
| Joel Mayersohn | 1 | 2 |
| Christopher M Nelson | 1 | 2 |
| Adam King | 1 | 2 |
| William Zell | 1 | 2 |
| Scott D. Whitney | 1 | 1 |
| J Lloyd Breedlove | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.